The Hidden Risks of Delta-8, Delta-10, and Other Unregulated Cannabinoids in Vapes

Hemp-derived intoxicating cannabinoids (delta-8-THC, delta-10-THC, CBN, CBG) are proliferating in largely unregulated vaping products. Chronic cannabis vapor exposure causes adverse brain and pulmonary effects. The 0.3% delta-9-THC limit has created a loophole allowing potent but unstudied THC isomers to reach consumers, particularly youth.

Review examining the pharmacology, toxicity, potential therapeutic uses, and health risks of several THC isomers and hemp-derived cannabinoids, with attention to secondary exposure risks and molecular mechanisms.

Youth are increasingly using vaping products containing THC variants that have essentially no safety data. The regulatory gap created by the 2018 Farm Bill means these products are widely available with no quality control or age restrictions in many jurisdictions.

The gap between rapidly evolving cannabis product markets and the slow pace of safety research creates a real-time public health experiment — with young people as the unwitting subjects.

Much of the evidence is indirect, extrapolated from delta-9-THC research. Long-term human studies on delta-8 and delta-10 THC are essentially nonexistent. Rapidly changing product landscape may outpace review findings.